Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in Dr Reddy s

Indian Pharma Sector: Time For A More Complex Game

With its cheap copies, India turned into the pharmacy of the world. But it’s time to move beyond exporting vanilla generics and on to manufacturing complex drugs

Read More

Sensex Falls 73 Points On Profit Booking In Pharma, Banking Stocks

After opening lower, the BSE barometer touched a low of 32,104.66 as investors booked profits in recent gainers

Read More

Sensex, Nifty Retreat From Record Highs On F&O Expiry

During the day, the barometer rallied over 260 points to touch fresh high of 32,642.91 following buying spree in financials, banks, realty, auto, IT, FMCG and oil & gas stocks

Read More

Sensex Ends 244 Points Up On Earnings Lift, Funds Inflows

The market opened positive on overnight earning numbers of FMCG major Hindustan Unilever coupled with a firming trend at other Asian markets

Read More

Dr Reddy's Sees No Impact From Pricing Regulator Notice

Dr Reddy's Laboratories Ltd, India's second-largest drugmaker by sales, said it expects no impact from a recent government notice that said the company is selling a high blood pressure drug that lacks the pricing regulator's approval.

Read More

Lupin Says It Sees No Supply Disruption At Plant Despite FDA Observations

The company said it did not expect any disruption to supply from its main manufacturing plant despite what it called minor observations made by the US Food and Drug Administration after an audit

Read More

Pharmaceutical Sector Grows 12 Per Cent In February: Report

Domestic companies grew at a modest pace of 14 per cent as against 19.4 per cent in the same period last year, and an average of 13.3 per cent since April 2015

Read More